NDC 50090-0481-01 - Naproxen
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-0481
- Requested NDC
- 50090-0481-01
- Package NDCs from labels
- 50090-0481-0, 50090-0481-7, 50090-0481-4, 50090-0481-5, 50090-0481-1, 50090-0481-9, 50090-0481-2, 50090-0481-6, 50090-0481-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2026-01-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Naproxen - A-S Medication Solutions | A-S Medication Solutions | 2026-01-29 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-0481-0 | Naproxen | 15 in 1 BOTTLE | TABLET | 15 | 31 | |
| 50090-0481-1 | Naproxen | 20 in 1 BOTTLE | TABLET | 20 | 31 | |
| 50090-0481-2 | Naproxen | 30 in 1 BOTTLE | TABLET | 30 | 31 | |
| 50090-0481-4 | Naproxen | 14 in 1 BOTTLE | TABLET | 14 | 31 | |
| 50090-0481-5 | Naproxen | 40 in 1 BOTTLE | TABLET | 40 | 31 | |
| 50090-0481-6 | Naproxen | 100 in 1 BOTTLE | TABLET | 100 | 31 | |
| 50090-0481-7 | Naproxen | 60 in 1 BOTTLE | TABLET | 60 | 31 | |
| 50090-0481-9 | Naproxen | 6 in 1 BOTTLE | TABLET | 6 | 31 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-0481 | NAPROXEN TABLET [A-S MEDICATION SOLUTIONS] | 29 | Current NDC, Legacy NDC, 8 package rows | 20240905_000155a8-709c-44e5-a75f-cd890f3a7caf.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-0481-0 | EA - Each | 50090-0481 | b73d0457-aa5d-44d1-9ffe-8e84bc4b53d5 | 1 | 2018-09-05 |
| 50090-0481-1 | EA - Each | 50090-0481 | 8d86527d-2599-4a30-82a6-c2dbd1b98722 | 1 | 2018-09-05 |
| 50090-0481-2 | EA - Each | 50090-0481 | d92301e9-5ae9-43b2-b86b-e58dad9eaea9 | 1 | 2018-09-05 |
| 50090-0481-4 | EA - Each | 50090-0481 | 1442acf3-7793-4a96-8ebf-f200f2e60bce | 1 | 2018-09-05 |
| 50090-0481-5 | EA - Each | 50090-0481 | bac00d6f-6aa6-473b-a517-2d181646cda1 | 1 | 2018-09-05 |
| 50090-0481-6 | EA - Each | 50090-0481 | 3c8620e3-6f7e-46f4-a0de-5ad10fba1c21 | 1 | 2018-09-05 |
| 50090-0481-7 | EA - Each | 50090-0481 | 33b2100d-a17f-4f6d-bad0-120a73bada72 | 1 | 2018-09-05 |
| 50090-0481-9 | EA - Each | 50090-0481 | 08fbf0d0-348d-48a8-b1a1-760f87e60643 | 1 | 2018-09-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Calamine | CALAMINE AND ZINC OXIDE | Pharma Nobis, LLC | fbcfa541-beda-06de-e053-6294a90a9298 | 2026-05-26 | Warnings | 1K09F3G675 |
| Naproxen Sodium | NAPROXEN SODIUM | PD-Rx Pharmaceuticals, Inc. | c5146d73-2f34-4dfe-ac29-97071279dc4d | 2026-05-26 | Warnings | 9TN87S3A3C |
| Ripple | GLYCERIN, POVIDONE | CorneaCare Inc | 3b5ba197-d501-681e-e063-6294a90aefb5 | 2026-05-24 | Warnings | FZ989GH94E |
| Berkley and Jensen Naproxen Sodium | NAPROXEN SODIUM | BJWC | 9530b649-3e01-452c-99a6-cff47fa4085b | 2026-05-21 | Warnings | 9TN87S3A3C |
| Naproxen | NAPROXEN | Redpharm Drug | 52503536-593e-808b-e063-6294a90a737f | 2026-05-21 | Boxed warning, Warnings, Adverse reactions | 198014 57Y76R9ATQ |
| Naproxen Sodium | NAPROXEN SODIUM | ST. MARY'S MEDICAL PARK PHARMACY | 181c2d5b-2c61-bf20-e063-6294a90a3f7f | 2026-05-20 | Boxed warning, Warnings, Adverse reactions | 849431 9TN87S3A3C |
| Naproxen | NAPROXEN | Bryant Ranch Prepack | 0041b483-34db-49a6-8665-f87e286cd0b8 | 2026-05-19 | Boxed warning, Warnings, Adverse reactions | ANDA078250 198012 57Y76R9ATQ |
| Naproxen | NAPROXEN | Bryant Ranch Prepack | 2e72de28-e62b-44e0-b17d-500d13e0bcc6 | 2026-05-15 | Boxed warning, Warnings, Adverse reactions | 198013 57Y76R9ATQ |
| Naproxen | NAPROXEN | Bryant Ranch Prepack | bbc61c0a-491a-4f50-a7bf-2ca94c771568 | 2026-05-15 | Boxed warning, Warnings, Adverse reactions | 198012 57Y76R9ATQ |
| Naproxen Sodium | NAPROXEN SODIUM | Rite Aid Corporation | e6277515-c606-4535-9c29-08cade045aee | 2026-05-14 | Warnings | 9TN87S3A3C |
| Naproxen Sodium | NAPROXEN SODIUM | CVS Pharmacy | c194124b-a5f6-423e-bc9a-7b611df990a8 | 2026-05-13 | Warnings | 9TN87S3A3C |
| naproxen sodium | NAPROXEN SODIUM | Bionpharma Inc. | 9343c79f-9994-4599-bcfe-0a93e49d726e | 2026-05-12 | Warnings | 9TN87S3A3C |
| Mucinex DS 12HR COLD, FEVER and SINUS | NAPROXEN SODIUM, PSEUDOEPHEDRINE HYDROCHLORIDE | Reckitt Benckiser LLC | 4e7e6674-c1ce-ea61-e063-6294a90afe04 | 2026-05-12 | Warnings | 9TN87S3A3C |
| good sense naproxen sodium | DIPHENHYDRAMINE HYDROCHLORIDE, NAPROXEN SODIUM | L. Perrigo Company | f548aa3d-b35e-458a-9815-3595a451ab78 | 2026-05-11 | Warnings | 9TN87S3A3C |
| Calamine Plus Pramoxine HCl | CALAMINE PLUS SPRAY | CVS Pharmacy | db6f518d-3a0e-43f8-8d19-7382d9b7ff1c | 2026-05-11 | Warnings | 1K09F3G675 |
| Good Sense Naproxen Sodium | NAPROXEN SODIUM | L. Perrigo Company | 8e150c00-8e5b-40b4-a964-cb70442c2752 | 2026-05-11 | Warnings | 9TN87S3A3C |
| equaline naproxen sodium | NAPROXEN SODIUM | United Natural Foods, Inc. dba UNFI | 89c02e55-fa08-4001-96fc-8a01e7e74d5a | 2026-05-06 | Warnings | 9TN87S3A3C |
| all day relief | NAPROXEN SODIUM | Publix Super Markets Inc | 0f8843be-50a3-442c-9016-d9da3b444f60 | 2026-05-06 | Warnings | 9TN87S3A3C |
| rugby all day relief | NAPROXEN SODIUM | Rugby Laboratories | f587a428-291c-4c54-80fe-244a961b0521 | 2026-05-06 | Warnings | 9TN87S3A3C |
| Calamine | FERRIC OXIDE RED | Retail Business Services, LLC | 7291e175-a9b6-4c47-93ce-227ce11e4599 | 2026-04-30 | Warnings, Adverse reactions | 1K09F3G675 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.